DEFA14A: ResMed Inc. to Hold Annual Meeting on November 20, 2024, to Elect Directors and Ratify Auditor
Proxy Statement
ResMed Inc. will hold its annual meeting on November 20, 2024, to vote on the election of directors, ratification of the auditor, and executive compensation.
Summary
- ResMed Inc. is holding its annual meeting on November 20, 2024 (US Pacific Time) / November 21, 2024 (Singapore and Australian Time).
- Shareholders will vote on electing 11 directors to serve until the 2025 annual meeting.
- The nominees include Carol Burt, Christopher DelOrefice, Jan De Witte, Karen Drexler, Michael Farrell, Peter Farrell, Harjit Gill, John Hernandez, Richard Sulpizio, Desney Tan, and Ronald Taylor.
- Shareholders will also vote to ratify the selection of KPMG LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2025.
- An advisory vote will be held to approve the compensation paid to the named executive officers.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions.
Positives
- The document provides clear information on how to vote, either online or by requesting materials.
- Shareholders have the opportunity to influence the company's direction through voting on key proposals.
Future Outlook
The document outlines the matters to be voted on at the upcoming annual meeting, providing shareholders with the opportunity to influence the company's governance and direction.
Industry Context
This is a standard proxy statement related to an annual meeting, a common practice for publicly traded companies to engage with shareholders on key decisions.
Stakeholder Impact
- Shareholders can influence the company's governance through their votes.
- The outcome of the votes will impact the composition of the board of directors and the selection of the auditor.
Next Steps
- Shareholders should review the proxy materials and vote on the proposals.
- Attend the annual meeting virtually or in person.
Key Dates
| Date | Description |
|---|---|
| November 6, 2024 | Deadline to request a copy of the proxy materials. |
| November 20, 2024 | Date of the Annual Meeting (US Pacific Time). |
| November 21, 2024 | Date of the Annual Meeting (Singapore and Australian Time). |
| June 30, 2025 | End of the fiscal year for which KPMG LLP is being considered as the auditor. |
Keywords
Annual Meeting, ResMed, Directors, KPMG, Proxy Statement, Shareholders, Voting, Executive Compensation, Auditor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.